Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015, Article ID 680145, 13 pages
http://dx.doi.org/10.1155/2015/680145
Research Article

Inhibition of Osteoclast Activation by Phloretin through Disturbing αvβ3 Integrin-c-Src Pathway

Department of Food Science and Nutrition, Hallym University, Chuncheon 200-702, Republic of Korea

Received 28 November 2014; Revised 31 January 2015; Accepted 17 February 2015

Academic Editor: Kenneth R. Hallows

Copyright © 2015 Eun-Jung Lee et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. H. C. Sheng and K. H. W. Lau, “Role of protein-tyrosine phosphatases in regulation of osteoclastic activity,” Cellular and Molecular Life Sciences, vol. 66, no. 11-12, pp. 1946–1961, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. Z. Bar-Shavit, “The osteoclast: a multinucleated, hematopoietic-origin, bone-resorbing osteoimmune cell,” Journal of Cellular Biochemistry, vol. 102, no. 5, pp. 1130–1139, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. T. D. Rachner, S. Khosla, and L. C. Hofbauer, “Osteoporosis: now and the future,” The Lancet, vol. 377, no. 9773, pp. 1276–1287, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. N. E. Lane, W. Yao, M. C. Nakamura et al., “Mice lacking the integrin β5 subunit have accelerated osteoclast maturation and increased activity in the estrogen-deficient state,” Journal of Bone and Mineral Research, vol. 20, no. 1, pp. 58–66, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. L. C. Hofbauer and A. E. Heufelder, “Role of receptor activator of nuclear factor-κB ligand and osteoprotegerin in bone cell biology,” Journal of Molecular Medicine, vol. 79, no. 5-6, pp. 243–253, 2001. View at Publisher · View at Google Scholar · View at Scopus
  6. M. F. Faienza, A. Ventura, F. Marzano, and L. Cavallo, “Postmenopausal osteoporosis: the role of immune system cells,” Clinical and Developmental Immunology, vol. 2013, Article ID 575936, 6 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. J.-L. Kim, Y.-H. Kim, M.-K. Kang, J.-H. Gong, S.-J. Han, and Y.-H. Kang, “Antiosteoclastic activity of milk thistle extract after ovariectomy to suppress estrogen deficiency-induced osteoporosis,” BioMed Research International, vol. 2013, Article ID 919374, 11 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. J. S. Chen and P. N. Sambrook, “Antiresorptive therapies for osteoporosis: a clinical overview,” Nature Reviews Endocrinology, vol. 8, no. 2, pp. 81–91, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. K. Åkesson, “New approaches to pharmacological treatment of osteoporosis,” Bulletin of the World Health Organization, vol. 81, no. 9, pp. 657–664, 2003. View at Google Scholar · View at Scopus
  10. H. Touaitahuata, A. Blangy, and V. Vives, “Modulation of osteoclast differentiation and bone resorption by Rho GTPases,” Small GTPases, vol. 5, no. 1, Article ID e28119, 2014. View at Publisher · View at Google Scholar
  11. D. V. Novack and R. Faccio, “Osteoclast motility: putting the brakes on bone resorption,” Ageing Research Reviews, vol. 10, no. 1, pp. 54–61, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. F. Coury, S. Zenger, A. K. Stewart et al., “SLC4A2-mediated Cl-/HCO3- exchange activity is essential for calpain-dependent regulation of the actin cytoskeleton in osteoclasts,” Proceedings of the National Academy of Sciences of the United States of America, vol. 110, no. 6, pp. 2163–2168, 2013. View at Publisher · View at Google Scholar
  13. S. L. Teitelbaum, “The osteoclast and its unique cytoskeleton,” Annals of the New York Academy of Sciences, vol. 1240, no. 1, pp. 14–17, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. P. Jurdic, F. Saltel, A. Chabadel, and O. Destaing, “Podosome and sealing zone: specificity of the osteoclast model,” European Journal of Cell Biology, vol. 85, no. 3-4, pp. 195–202, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. I. Nakamura, L. T. Duong, S. B. Rodan, and G. A. Rodan, “Involvement of αvβ3 integrins in osteoclast function,” Journal of Bone and Mineral Metabolism, vol. 25, no. 6, pp. 337–344, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. T. Izawa, W. Zou, J. C. Chappel, J. W. Ashley, X. Feng, and S. L. Teitelbaum, “c-Src links a RANK/αvβ3 integrin complex to the osteoclast cytoskeleton,” Molecular and Cellular Biology, vol. 32, no. 14, pp. 2943–2953, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. A. F. Al-Anazi, V. F. Qureshi, K. Javaid, and S. Qureshi, “Preventive effects of phytoestrogens against postmenopausal osteoporosis as compared to the available therapeutic choices: an overview,” Journal of Natural Science, Biology and Medicine, vol. 2, no. 2, pp. 154–163, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. J. Banu, E. Varela, and G. Fernandes, “Alternative therapies for the prevention and treatment of osteoporosis,” Nutrition Reviews, vol. 70, no. 1, pp. 22–40, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. J. V. Turner, S. Agatonovic-Kustrin, and B. D. Glass, “Molecular aspects of phytoestrogen selective binding at estrogen receptors,” Journal of Pharmaceutical Sciences, vol. 96, no. 8, pp. 1879–1885, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. S. Bedell, M. Nachtigall, and F. Naftolin, “The pros and cons of plant estrogens for menopause,” Journal of Steroid Biochemistry and Molecular Biology, vol. 139, pp. 225–236, 2014. View at Publisher · View at Google Scholar · View at Scopus
  21. K. Taku, M. K. Melby, F. Kronenberg, M. S. Kurzer, and M. Messina, “Extracted or synthesized soybean isoflavones reduce menopausal hot flash frequency and severity: systematic review and meta-analysis of randomized controlled trials,” Menopause, vol. 19, no. 7, pp. 776–790, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. K. Hagiwara, T. Goto, M. Araki, H. Miyazaki, and H. Hagiwara, “Olive polyphenol hydroxytyrosol prevents bone loss,” European Journal of Pharmacology, vol. 662, no. 1-3, pp. 78–84, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. M. Kamon, R. Zhao, and K. Sakamoto, “Green tea polyphenol (-)-epigallocatechin gallate suppressed the differentiation of murine osteoblastic MC3T3-E1 cells,” Cell Biology International, vol. 34, no. 1, pp. 109–116, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. J.-L. Kim, M.-K. Kang, J.-H. Gong, S.-H. Park, S.-Y. Han, and Y.-H. Kang, “Novel antiosteoclastogenic activity of phloretin antagonizing RANKL-induced osteoclast differentiation of murine macrophages,” Molecular Nutrition and Food Research, vol. 56, no. 8, pp. 1223–1233, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. E. J. Lee, J. L. Kim, Y. H. Kim, M. K. Kang, J. H. Gong, and Y. H. Kang, “Phloretin promotes osteoclast apoptosis in murine macrophages and inhibits estrogen deficiency-induced osteoporosis in mice,” Phytomedicine, vol. 21, pp. 1208–1215, 2014. View at Publisher · View at Google Scholar · View at Scopus
  26. K. Hara, M. Kobayashi, and Y. Akiyama, “Influence of bone osteocalcin levels on bone loss induced by ovariectomy in rats,” Journal of Bone and Mineral Metabolism, vol. 25, no. 6, pp. 345–353, 2007. View at Publisher · View at Google Scholar · View at Scopus
  27. A. Qin, T. S. Cheng, N. J. Pavlos, Z. Lin, K. R. Dai, and M. H. Zheng, “V-ATPases in osteoclasts: structure, function and potential inhibitors of bone resorption,” International Journal of Biochemistry and Cell Biology, vol. 44, no. 9, pp. 1422–1435, 2012. View at Publisher · View at Google Scholar · View at Scopus
  28. W.-C. Xiong and X. Feng, “PYK2 and FAK in osteoclasts,” Frontiers in Bioscience, vol. 8, pp. d1219–d1226, 2003. View at Publisher · View at Google Scholar · View at Scopus
  29. A. Sanjay, A. Houghton, L. Neff et al., “Cbl associates with Pyk2 and Src to regulate Src kinase activity, αvβ3 integrin-mediated signaling, cell adhesion, and osteoclast motility,” Journal of Cell Biology, vol. 152, no. 1, pp. 181–195, 2001. View at Publisher · View at Google Scholar · View at Scopus
  30. C. E. Turner, “Paxillin and focal adhesion signalling,” Nature Cell Biology, vol. 2, no. 12, pp. E231–E236, 2000. View at Publisher · View at Google Scholar · View at Scopus
  31. W. Zou, M. Croke, T. Fukunaga, T. J. Broekelmann, R. P. Mecham, and S. L. Teitelbaum, “Zap70 inhibits Syk-mediated osteoclast function,” Journal of Cellular Biochemistry, vol. 114, no. 8, pp. 1871–1878, 2013. View at Publisher · View at Google Scholar · View at Scopus
  32. Z. H. Lee and H.-H. Kim, “Signal transduction by receptor activator of nuclear factor kappa B in osteoclasts,” Biochemical and Biophysical Research Communications, vol. 305, no. 2, pp. 211–214, 2003. View at Publisher · View at Google Scholar · View at Scopus
  33. E. M. Stein, A. Kepley, M. Walker et al., “Skeletal structure in postmenopausal women with osteopenia and fractures is characterized by abnormal trabecular plates and cortical thinning,” Journal of Bone and Mineral Research, vol. 29, no. 5, pp. 1101–1109, 2014. View at Publisher · View at Google Scholar · View at Scopus
  34. M. K. Beard, “Bisphosphonate therapy for osteoporosis: combining optimal fracture risk reduction with patient preference,” Current Medical Research and Opinion, vol. 28, no. 1, pp. 141–147, 2012. View at Publisher · View at Google Scholar · View at Scopus
  35. B. Dawson-Hughes and H. A. Bischoff-Ferrari, “Therapy of osteoporosis with calcium and vitamin D,” Journal of Bone and Mineral Research, vol. 22, supplement 2, pp. V59–V63, 2007. View at Publisher · View at Google Scholar · View at Scopus
  36. N. Takahashi, S. Ejiri, S. Yanagisawa, and H. Ozawa, “Regulation of osteoclast polarization,” Odontology, vol. 95, no. 1, pp. 1–9, 2007. View at Publisher · View at Google Scholar · View at Scopus
  37. K. A. Szewczyk, K. Fuller, and T. J. Chambers, “Distinctive subdomains in the resorbing surface of osteoclasts,” PLoS ONE, vol. 8, no. 3, Article ID e60285, 2013. View at Publisher · View at Google Scholar · View at Scopus
  38. V. Beaulieu, N. Da Silva, N. Pastor-Soler et al., “Modulation of the actin cytoskeleton via gelsolin regulates vacuolar H+-ATPase recycling,” The Journal of Biological Chemistry, vol. 280, no. 9, pp. 8452–8463, 2005. View at Publisher · View at Google Scholar · View at Scopus
  39. T. Fukunaga, W. Zou, J. T. Warren, and S. L. Teitelbaum, “Vinculin regulates osteoclast function,” Journal of Biological Chemistry, vol. 289, no. 19, pp. 13554–13564, 2014. View at Publisher · View at Google Scholar · View at Scopus
  40. H. J. Knowles and N. A. Athanasou, “Hypoxia-inducible factor is expressed in giant cell tumour of bone and mediates paracrine effects of hypoxia on monocyte-osteoclast differentiation via induction of VEGF,” Journal of Pathology, vol. 215, no. 1, pp. 56–66, 2008. View at Publisher · View at Google Scholar · View at Scopus